Drug Patents owned by Jazz Pharms
1. Drug name - XYREM
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8731963 | JAZZ PHARMS | Sensitive drug distribution system and method |
Dec, 2022
(2 months from now) | |
|
US8731963
(Pediatric) | JAZZ PHARMS | Sensitive drug distribution system and method |
Jun, 2023
(8 months from now) | |
| US7668730 | JAZZ PHARMS | Sensitive drug distribution system and method |
Jun, 2024
(1 year, 8 months from now) | |
|
US7668730
(Pediatric) | JAZZ PHARMS | Sensitive drug distribution system and method |
Dec, 2024
(2 years from now) | |
| US10864181 | JAZZ PHARMS | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(10 years from now) | |
| US10213400 | JAZZ PHARMS | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(10 years from now) | |
| US9486426 | JAZZ PHARMS | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(10 years from now) | |
| US9050302 | JAZZ PHARMS | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(10 years from now) | |
| US8772306 | JAZZ PHARMS | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Mar, 2033
(10 years from now) | |
|
US8772306
(Pediatric) | JAZZ PHARMS | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Sep, 2033
(10 years from now) | |
|
US9486426
(Pediatric) | JAZZ PHARMS | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Sep, 2033
(10 years from now) | |
|
US9050302
(Pediatric) | JAZZ PHARMS | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
Sep, 2033
(10 years from now) | |
Drugs and Companies using SODIUM OXYBATE ingredient
Treatment: Method of treating a patient with a prescription drug using a computer database in a computer system for distribution; Method of treating excessive daytime sleepiness and/or cataplexy in narcolepsy patients with sodium oxybate when divalproex sodium is concomitantly administered.; Method of reducing adverse effects in patients suffering from excessive daytime sleepiness and/or cataplexy in narcolepsy who are concomitantly administered sodium oxybate and divalproex sodium
Dosage: SOLUTION;ORAL
| Strength | Dosage | Availability |
|---|---|---|
| 0.5GM/ML | SOLUTION;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.